• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

犬恶性乳腺肿瘤伴淋巴结或肺转移三阴性模型中VEGFR-2和PDGFR表达及微血管密度的失调

Deregulation of VEGFR-2 and PDGFR Expression and Microvascular Density in a Triple-Negative Model of Canine Malignant Mammary Tumors with Lymph Node or Lung Metastasis.

作者信息

Dos Anjos Denner Santos, Vital Aline Fernandes, Lainetti Patrícia de Faria, Leis-Filho Antonio Fernando, Dalmolin Fabiola, Elias Fabiana, Calazans Sabryna Gouveia, Fonseca-Alves Carlos Eduardo

机构信息

Veterinary Science Graduate Program, University of Franca (UNIFRAN), Franca 14404-600, Brazil.

Department of Veterinary Surgery and Anesthesiology, School of Veterinary Medicine and Animal Science, São Paulo State University-UNESP, Botucatu 18618-681, Brazil.

出版信息

Vet Sci. 2019 Jan 9;6(1):3. doi: 10.3390/vetsci6010003.

DOI:10.3390/vetsci6010003
PMID:30634402
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6466043/
Abstract

Canine mammary tumors (CMT) represent the most common cancer in noncastrated female dogs. Interestingly, triple-negative tumors are the most common molecular subtype in female dogs. In this study, we proposed to evaluate the expression of vascular endothelial growth factor receptor 2 (VEGFR-2), Platelet-derived growth factor receptor (PDGFR), and microvascular density (MVD) in a group of metastatic and nonmetastatic triple-negative CMT and compare the expression based on clinical parameters. Twenty-six female dogs with triple-negative mammary tumors were divided into three groups: nonmetastatic tumors (NMT) ( = 11), tumors with lymph node metastasis (LNM) ( = 10), and tumors with lung metastasis (LM) ( = 5). We observed increased VEGFR-2 expression in LNM compared with NMT and a positive correlation between tumor grade and VEGFR-2 expression. A positive correlation was noted between VEGFR-2 and PDGFR expression. Regarding microvascular density (MVD), we identified a higher number of vessels in primary tumors with lymph node metastasis and lung metastasis compared with tumors with no metastasis. The primary tumors with lung metastasis exhibited an increased MVD compared with carcinoma with lymph node metastasis. Overall, our results suggest a deregulation of VEGFR-2 and PDGFR and high MVD in metastatic tumors, indicating a role for angiogenesis in tumor progression.

摘要

犬乳腺肿瘤(CMT)是未绝育雌性犬中最常见的癌症。有趣的是,三阴性肿瘤是雌性犬中最常见的分子亚型。在本研究中,我们提议评估一组转移性和非转移性三阴性CMT中血管内皮生长因子受体2(VEGFR-2)、血小板衍生生长因子受体(PDGFR)的表达以及微血管密度(MVD),并根据临床参数比较其表达情况。26只患有三阴性乳腺肿瘤的雌性犬被分为三组:非转移性肿瘤(NMT)(n = 11)、有淋巴结转移的肿瘤(LNM)(n = 10)和有肺转移的肿瘤(LM)(n = 5)。我们观察到,与NMT相比,LNM中VEGFR-2表达增加,且肿瘤分级与VEGFR-2表达之间呈正相关。VEGFR-2与PDGFR表达之间也呈正相关。关于微血管密度(MVD),我们发现与无转移的肿瘤相比,有淋巴结转移和肺转移的原发性肿瘤中的血管数量更多。与有淋巴结转移的癌相比,有肺转移的原发性肿瘤的MVD增加。总体而言,我们的结果表明转移性肿瘤中VEGFR-2和PDGFR失调且MVD较高,表明血管生成在肿瘤进展中起作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4ed/6466043/44c4378a049c/vetsci-06-00003-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4ed/6466043/294d703f9eca/vetsci-06-00003-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4ed/6466043/c8513b2c3ff5/vetsci-06-00003-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4ed/6466043/3829e5f321c3/vetsci-06-00003-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4ed/6466043/44c4378a049c/vetsci-06-00003-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4ed/6466043/294d703f9eca/vetsci-06-00003-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4ed/6466043/c8513b2c3ff5/vetsci-06-00003-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4ed/6466043/3829e5f321c3/vetsci-06-00003-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4ed/6466043/44c4378a049c/vetsci-06-00003-g004.jpg

相似文献

1
Deregulation of VEGFR-2 and PDGFR Expression and Microvascular Density in a Triple-Negative Model of Canine Malignant Mammary Tumors with Lymph Node or Lung Metastasis.犬恶性乳腺肿瘤伴淋巴结或肺转移三阴性模型中VEGFR-2和PDGFR表达及微血管密度的失调
Vet Sci. 2019 Jan 9;6(1):3. doi: 10.3390/vetsci6010003.
2
Co-expression of PDGF-B and VEGFR-3 strongly correlates with lymph node metastasis and poor survival in non-small-cell lung cancer.血小板衍生生长因子-B(PDGF-B)和血管内皮生长因子受体-3(VEGFR-3)的共表达与非小细胞肺癌的淋巴结转移和不良预后密切相关。
Ann Oncol. 2010 Feb;21(2):223-231. doi: 10.1093/annonc/mdp296. Epub 2009 Jul 23.
3
Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma.血管内皮生长因子(VEGF)及其受体(Flt-1和Flk-1)在食管鳞状细胞癌中的表达
Anticancer Res. 2002 Nov-Dec;22(6C):3977-84.
4
Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling.通过阻断血管内皮生长因子受体3信号通路抑制肿瘤淋巴管生成和淋巴结转移
J Natl Cancer Inst. 2002 Jun 5;94(11):819-25. doi: 10.1093/jnci/94.11.819.
5
[Expression of vascular endothelial growth factor (VEGF) C and VEGF receptor 3 in non-small cell lung cancer].血管内皮生长因子(VEGF)C和VEGF受体3在非小细胞肺癌中的表达
Zhonghua Bing Li Xue Za Zhi. 2003 Apr;32(2):128-32.
6
Determination of microvessel density by quantitative real-time PCR in esophageal cancer: correlation with histologic methods, angiogenic growth factor expression, and lymph node metastasis.通过定量实时聚合酶链反应测定食管癌微血管密度:与组织学方法、血管生成生长因子表达及淋巴结转移的相关性
Clin Cancer Res. 2007 Jan 1;13(1):76-80. doi: 10.1158/1078-0432.CCR-06-1324.
7
The correlation and clinical implication of VEGF-C expression in microvascular density and lymph node metastasis of gastric carcinoma.血管内皮生长因子-C(VEGF-C)表达与胃癌微血管密度及淋巴结转移的相关性及临床意义
Am J Transl Res. 2016 Dec 15;8(12):5741-5747. eCollection 2016.
8
PDGFR-α, PDGFR-β, VEGFR-2 and CD117 expression in canine mammary tumours and evaluation of the in vitro effects of toceranib phosphate in neoplastic mammary cell lines.犬乳腺肿瘤中 PDGFR-α、PDGFR-β、VEGFR-2 和 CD117 的表达及磷酸替莫唑胺在肿瘤乳腺细胞系中的体外作用评价。
Vet Rec. 2018 Aug 18;183(7):221. doi: 10.1136/vr.104414. Epub 2018 Feb 9.
9
Different role of COX-2 and angiogenesis in canine inflammatory and non-inflammatory mammary cancer.COX-2 和血管生成在犬炎性和非炎性乳腺癌中的不同作用。
Vet J. 2013 Aug;197(2):427-32. doi: 10.1016/j.tvjl.2013.02.009. Epub 2013 Mar 11.
10
Endothelial VEGFR-3 expression in colorectal carcinomas is associated with hematogenous metastasis.结直肠癌中内皮细胞血管内皮生长因子受体-3的表达与血行转移相关。
Oncol Rep. 2009 Nov;22(5):1093-100. doi: 10.3892/or_00000541.

引用本文的文献

1
In Silico and In Vitro Evaluation of Bevacizumab Biosimilar MB02 as an Antitumor Agent in Canine Mammary Carcinoma.贝伐单抗生物类似药MB02作为犬乳腺癌抗肿瘤药物的计算机模拟和体外评价
Animals (Basel). 2023 Aug 3;13(15):2507. doi: 10.3390/ani13152507.
2
Firocoxib as a Potential Neoadjuvant Treatment in Canine Patients with Triple-Negative Mammary Gland Tumors.非甾体类抗炎药氟罗昔布作为三阴性乳腺肿瘤犬类患者潜在的新辅助治疗药物
Animals (Basel). 2022 Dec 23;13(1):60. doi: 10.3390/ani13010060.
3
Comparison of Biomarkers Between Hepatic Tumors in Rat Models and a Dog.

本文引用的文献

1
Recent advances in breast cancer research impacting clinical diagnostic practice.乳腺癌研究的最新进展对临床诊断实践产生影响。
J Pathol. 2019 Apr;247(5):552-562. doi: 10.1002/path.5199. Epub 2019 Jan 16.
2
Adjuvant Thalidomide and Metronomic Chemotherapy for the Treatment of Canine Malignant Mammary Gland Neoplasms.沙利度胺辅助与节拍化疗治疗犬恶性乳腺肿瘤
In Vivo. 2018 Nov-Dec;32(6):1659-1666. doi: 10.21873/invivo.11429.
3
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
大鼠模型与犬肝脏肿瘤标志物的比较
In Vivo. 2023 Jan-Feb;37(1):252-261. doi: 10.21873/invivo.13075.
4
VEGF Expression, Cellular Infiltration, and Intratumoral Collagen Levels after Electroporation-Based Treatment of Dogs with Cutaneous Squamous Cell Carcinoma.基于电穿孔治疗犬皮肤鳞状细胞癌后的血管内皮生长因子表达、细胞浸润及瘤内胶原水平
Life (Basel). 2021 Nov 30;11(12):1321. doi: 10.3390/life11121321.
5
From Conventional to Precision Therapy in Canine Mammary Cancer: A Comprehensive Review.从犬类乳腺癌的传统治疗到精准治疗:全面综述
Front Vet Sci. 2021 Feb 17;8:623800. doi: 10.3389/fvets.2021.623800. eCollection 2021.
6
Establishment and Characterization of Canine Mammary Gland Carcinoma Cell Lines With Vasculogenic Mimicry Ability and .具有血管生成拟态能力的犬乳腺癌细胞系的建立与鉴定 以及 。 (原文最后似乎不完整)
Front Vet Sci. 2020 Oct 27;7:583874. doi: 10.3389/fvets.2020.583874. eCollection 2020.
7
Know Thy Model: Charting Molecular Homology in Stromal Reprogramming Between Canine and Human Mammary Tumors.了解你的模型:绘制犬类和人类乳腺肿瘤间基质重编程中的分子同源性图谱。
Front Cell Dev Biol. 2019 Dec 17;7:348. doi: 10.3389/fcell.2019.00348. eCollection 2019.
8
Investigation of the Prognostic Significance of Vasculogenic Mimicry and Its Inhibition by Sorafenib in Canine Mammary Gland Tumors.犬乳腺肿瘤中血管生成拟态的预后意义及其被索拉非尼抑制的研究
Front Oncol. 2019 Dec 19;9:1445. doi: 10.3389/fonc.2019.01445. eCollection 2019.
全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
4
Tolerability of oral sorafenib in pet dogs with a diagnosis of cancer.口服索拉非尼在诊断为癌症的宠物狗中的耐受性。
Vet Med (Auckl). 2017 Dec 8;8:97-102. doi: 10.2147/VMRR.S149678. eCollection 2017.
5
Tyrosine kinase expression analyses in canine mammary gland tumours - A pilot study.犬乳腺肿瘤中酪氨酸激酶表达分析——一项初步研究。
Acta Vet Hung. 2018 Jun;66(2):294-308. doi: 10.1556/004.2018.027.
6
Immunohistochemical panel to characterize canine prostate carcinomas according to aberrant p63 expression.根据异常的 p63 表达对犬前列腺癌进行免疫组织化学特征分析的免疫组化面板。
PLoS One. 2018 Jun 12;13(6):e0199173. doi: 10.1371/journal.pone.0199173. eCollection 2018.
7
Canine invasive mammary carcinomas as models of human breast cancer. Part 2: immunophenotypes and prognostic significance.犬浸润性乳腺肿瘤作为人类乳腺癌模型。第 2 部分:免疫表型和预后意义。
Breast Cancer Res Treat. 2018 Jan;167(2):459-468. doi: 10.1007/s10549-017-4542-8. Epub 2017 Oct 23.
8
Expression and prognostic significance of VEGFR-2 in breast cancer.VEGFR-2在乳腺癌中的表达及其预后意义
Pathol Res Pract. 2015 Jul;211(7):539-43. doi: 10.1016/j.prp.2015.04.003. Epub 2015 Apr 17.
9
Very late relapse in breast cancer survivors: a report of 6 cases.乳腺癌幸存者的极晚期复发:6例报告
Iran J Cancer Prev. 2013 Spring;6(2):113-7.
10
CD117 expression influences proliferation but not survival in canine mammary tumours.CD117表达影响犬乳腺肿瘤的增殖,但不影响其存活。
J Comp Pathol. 2014 Aug-Oct;151(2-3):202-6. doi: 10.1016/j.jcpa.2014.04.018. Epub 2014 Jul 12.